Paper39304580
Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future.
Creary S and 3 others. Curr Neurol Neurosci Rep, 2024. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future. Papers, record 39304580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39304580
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia, Sickle Cell | Major topic |
| Stroke | Major topic |
| Humans | |
| Child | |
| Adolescent |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34530179 | Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke. | Transplant Cell Ther | 2021 | https://conductscience.org/library/papers/34530179 | PubMed |
| 2 | 12874397 | Risk of stroke in children: ethnic and gender disparities. | Neurology | 2003 | https://conductscience.org/library/papers/12874397 | PubMed |
| 3 | 17061288 | Etiology of strokes in children with sickle cell anemia. | Ment Retard Dev Disabil Res Rev | 2006 | https://conductscience.org/library/papers/17061288 | PubMed |
| 4 | 33283989 | CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33283989 | PubMed |
| 5 | 3086721 | Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3086721 | PubMed |
| 6 | 30076115 | The Genetic Landscape of Cerebral Steno-Occlusive Arteriopathy and Stroke in Sickle Cell Anemia. | J Stroke Cerebrovasc Dis | 2018 | https://conductscience.org/library/papers/30076115 | PubMed |
| 7 | 25140956 | Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25140956 | PubMed |
| 8 | 35964532 | Characteristics and outcomes of stroke hospitalizations in patients with sickle cell disease and moyamoya syndrome. | J Stroke Cerebrovasc Dis | 2022 | https://conductscience.org/library/papers/35964532 | PubMed |
| 9 | 20940417 | Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. | Blood | 2011 | https://conductscience.org/library/papers/20940417 | PubMed |
| 10 | 26670617 | Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. | Lancet | 2016 | https://conductscience.org/library/papers/26670617 | PubMed |
| 11 | 37883803 | Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease. | Blood Adv | 2024 | https://conductscience.org/library/papers/37883803 | PubMed |
| 12 | 33840223 | Cerebral Hemodynamics and Executive Function in Sickle Cell Anemia. | Stroke | 2021 | https://conductscience.org/library/papers/33840223 | PubMed |
| 13 | 26941400 | Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia. | Blood | 2016 | https://conductscience.org/library/papers/26941400 | PubMed |
| 14 | 30686119 | Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association. | Stroke | 2019 | https://conductscience.org/library/papers/30686119 | PubMed |
| 15 | 35132969 | Revascularization Is Associated With a Reduced Stroke Risk in Patients With Sickle Cell-Associated Moyamoya Syndrome. | Neurosurgery | 2022 | https://conductscience.org/library/papers/35132969 | PubMed |
| 16 | 25837886 | Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease. | J Neurosurg Pediatr | 2015 | https://conductscience.org/library/papers/25837886 | PubMed |
| 17 | 37892248 | Executive Function and Processing Speed in Children Living with Sickle Cell Anemia. | Children (Basel) | 2023 | https://conductscience.org/library/papers/37892248 | PubMed |
| 18 | 29542687 | Sickle cell disease. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29542687 | PubMed |
| 19 | 34077859 | Stroke and stroke prevention in sickle cell anemia in developed and selected developing countries. | J Neurol Sci | 2021 | https://conductscience.org/library/papers/34077859 | PubMed |
| 20 | 26492583 | Transitioning Adolescents and Young Adults With Sickle Cell Disease From Pediatric to Adult Health Care: Provider Perspectives. | J Pediatr Hematol Oncol | 2015 | https://conductscience.org/library/papers/26492583 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39304580
GET https://conductscience.org/api/papers/v1/39304580/references?page=2